MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway

被引:31
|
作者
Ai, WD
Gong, JH
Yu, L [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[2] Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA
关键词
Mu opioid receptor; mitogen-activated protein kinase; protein kinase A; phosphatidylinositol; 3-kinase;
D O I
10.1016/S0014-5793(99)00949-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The involvement of protein kinases was studied in mu opioid receptor activation of mitogen-activated protein (MAP) kinase using cells transfected with the receptor clone. The cAMP/protein kinase A (PKA) pathway is known to be the major biochemical pathway For mu opioid receptor signaling, However, our data showed that stimulating adenylyl cyclase or activating PKA had no effect on mu receptor enhancement of MAP kinase activity, suggesting that the cAMP/PKA. pathway is not involved in mediating the mu receptor activation of MAP, kinase, Inhibition of phosphatidylinositol (PI) 3-kinase reduced mu receptor enhancement of MAP kinase activity, suggesting IPI 3-kinase involvement, Together, these results show that crosstalk between the mu opioid receptor and the MAP kinase cascade is not mediated by the cAMP/PKA pathway, but involves PI 3-kinase, (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 50 条
  • [41] A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferation
    Lali, FV
    Crawley, J
    McCulloch, DA
    Foxwell, BMJ
    JOURNAL OF IMMUNOLOGY, 2004, 172 (06): : 3527 - 3534
  • [42] Phosphatidylinositol 3-kinase in myogenesis
    Kaliman, P
    Zorzano, A
    TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (06) : 198 - 202
  • [43] EVALUATION OF ELK-1 ACTIVATION BY PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY IN GLIOBLASTOMA
    Mut, Melike
    Isik, Sevda
    Demir, Ozlem
    Peynircioglu, Banu
    NEURO-ONCOLOGY, 2009, 11 (06) : 957 - 957
  • [44] EVALUATION OF ELK-1 ACTIVATION BY PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY IN GLIOBLASTOMA
    Mur, Melike
    Demir, Ozlem
    Kurnaz, Isil
    Akalan, Nejat
    NEURO-ONCOLOGY, 2008, 10 (05) : 770 - 770
  • [45] A Receptor-associated Protein/Phosphatidylinositol 3-Kinase Pathway Controls Pseudopod Formation
    Kortholt, Arjan
    Bolourani, Parvin
    Rehmann, Holger
    Keizer-Gunnink, Ineke
    Weeks, Gerald
    Wittinghofer, Alfred
    Van Haastert, Peter J. M.
    MOLECULAR BIOLOGY OF THE CELL, 2010, 21 (06) : 936 - 945
  • [46] Vps34 is a phosphatidylinositol 3-kinase, not a phosphoinositide 3-kinase
    Meijer, Alfred J.
    Klionsky, Daniel J.
    AUTOPHAGY, 2011, 7 (06) : 563 - 564
  • [47] Phosphatidylinositol 3-kinase interacts with the glucocorticoid receptor upon TLR2 activation
    Arancibia, Sergio
    Benitez, Dixan
    Nunez, Lucia E.
    Jewell, Christine M.
    Langjahr, Patricia
    Candia, Enzo
    Zapata-Torres, Gerald
    Cidlowski, John A.
    Gonzalez, Maria-Julieta
    Hermoso, Marcela A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (02) : 339 - 349
  • [48] Insulin signalling in heart involves insulin receptor substrates-1 and -2, activation of phosphatidylinositol 3-kinase and the JAK 2-growth related pathway
    Velloso, LA
    Carvalho, CRO
    Rojas, FA
    Folli, F
    Saad, MJA
    CARDIOVASCULAR RESEARCH, 1998, 40 (01) : 96 - 102
  • [49] Impedance of Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis by peroxisome proliferator-activated receptor γ activation involves phosphatidylinositol 3-kinase/ERK pathway
    Slomiany, BL
    Slomiany, A
    IUBMB LIFE, 2003, 55 (02) : 97 - 102
  • [50] Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer
    Hernandez-Aya, Leonel F.
    Gonzalez-Angulo, Ana M.
    ONCOLOGIST, 2011, 16 (04): : 404 - 414